cytokine-induced memory-like natural killer cells (Dana-Farber Cancer Institute)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namecytokine-induced memory-like natural killer cells (Dana-Farber Cancer Institute)
Drug Alias NameCIML NK cells
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesHead and Neck Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer Institute
Inactive CompaniesN/A
Active IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesHead and Neck Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A